North American Drug Delivery Technologies Market worth 758.75 Billion USD by 2021

1
MarketsandMarkets Presents
North American Drug Delivery Technologies Market
worth 758.75 Billion USD by 2021
http//www.marketsandmarkets.com/Market-Reports/no
rth-american-drug-delivery-technologies-market-120
9.html
2
The report "North American Drug Delivery
Technologies Market by Route of Administration
(Oral (Solid), Pulmonary (Nebulizer), Injectable
(Device), Ocular (Device), Nasal (Drop), Topical
(Solid), Implantable (Active)), End User
(Hospital, Home Care) - Global Forecast to 2021
The North American drug delivery technologies
market is projected to reach USD 758.7 Billion by
2021 from USD 520.0 Billion in 2016, at a CAGR of
6.5. Browse 206 market data Tables and 57
Figures spread through 275 Pages and in-depth TOC
on "North American Drug Delivery Technologies
Market http//www.marketsandmarkets.com/Market-R
eports/north-american-drug-delivery-technologies-m
arket-1209.html Early buyers will receive 10
customization on This report. Factors such as
rising prevalence of chronic diseases, growth in
the biologics market, funding initiatives for
drug delivery research, and technological
advancements are driving the growth of this
market. However, risk of needlestick injuries and
side effects related to drugs are expected to
restrain the growth of this market in the coming
years. .
http//www.marketsandmarkets.com/Market-Reports/no
rth-american-drug-delivery-technologies-market-120
9.html
3
Based on the route of administration, the North
American drug delivery technologies market is
segmented into oral, pulmonary, injectable,
ocular, nasal, topical, implantable, and
transmucosal drug delivery. The topical drug
delivery market is expected to grow at the
highest CAGR during the forecast period. The high
growth in this segment is attributed to the
advantages of topical drugs, such as convenience
and ease of use, right dosage to the right place,
painless application, noninvasive nature,
superior spreadability, and enhanced patient
compliance. On the basis of type, the oral drug
delivery technologies market is segmented into
solid, liquid, and semi-solid drug delivery.
Solid oral drug delivery is segmented into
tablets, capsules, pills, and powders. In 2016,
tablets are estimated to account for the largest
share of the solid oral drug delivery market.
High patient compliance and acceptability are the
major factors driving the growth of this market
segment.
http//www.marketsandmarkets.com/Market-Reports/no
rth-american-drug-delivery-technologies-market-120
9.html
4
The injectable drug delivery market is segmented
into two broad categories, namely, devices and
formulations. Devices are further subsegmented
into conventional and self-injectors, while
formulations are further categorized into
conventional, novel, and long-acting. In 2016,
novel drug delivery formulations are expected to
account for the largest share of the formulations
market. Enhanced efficacy, increased patient
compliance by decreasing dose frequency, and
targeted drug delivery (which reduces side
effects) are some of the key factors driving the
growth of this market segment. The Sample Report
For This Report_at_ http//www.marketsandmarkets.com
/requestsample.asp?id1209 Topical drug
delivery is segmented into solid, liquid,
semi-solid, and transdermal drug delivery.
Transdermal drug delivery is expected to register
the highest CAGR during the forecast period. The
noninvasive nature of this drug delivery system,
feasibility of self-administration, and improved
patient compliance are the major factors driving
the growth of the transdermal drug delivery
market.    
http//www.marketsandmarkets.com/Market-Reports/no
rth-american-drug-delivery-technologies-market-120
9.html
5
The North American drug delivery technologies
market is segmented on the basis of route of
administration, end user, and country. The U.S.
market is expected to dominate the North American
drug delivery technologies market in 2016 and is
projected to grow at the highest CAGR during the
forecast period. The large share of the U.S. in
the North American market can primarily be
attributed to factors such as the rising
prevalence of chronic diseases, rapidly growing
geriatric population, growth in the biologics
market, and growing regulatory approvals and new
product launches. Get The PDF Brochure For This
Report_at_ http//www.marketsandmarkets.com/pdfdownlo
ad.asp?id1209   Prominent players in this market
include Johnson Johnson, Inc. (U.S.), Merck
Co. Inc. (U.S.), Novartis AG (Switzerland), Bayer
AG (Germany), 3M Company (U.S.), F. Hoffmann-La
Roche (Switzerland), Becton, Dickinson and
Company (U.S.), GlaxoSmithKline (U.K.), Pfizer,
Inc. (U.S.), Antares Pharma (U.S.), and Sanofi
(France).  
http//www.marketsandmarkets.com/Market-Reports/no
rth-american-drug-delivery-technologies-market-120
9.html
6
About MarketsandMarkets MarketsandMarkets
provides quantified B2B research on 30,000 high
growth niche opportunities/threats which will
impact 70 to 80 of worldwide companies
revenues. Currently servicing 5000 customers
worldwide including 80 of global Fortune 1000
companies as clients. Almost 75,000 top officers
across eight industries worldwide approach
MarketsandMarkets for their painpoints around
revenues decisions.   Our 850 fulltime analyst
and SMEs at MarketsandMarkets are tracking
global high growth markets following the "Growth
Engagement Model GEM". The GEM aims at
proactive collaboration with the clients to
identify new opportunities, identify most
important customers, write "Attack, avoid and
defend" strategies, identify sources of
incremental revenues for both the company and its
competitors. MarketsandMarkets now coming up
with 1,500 MicroQuadrants (Positioning top
players across leaders, emerging companies,
innovators, strategic players) annually in high
growth emerging segments. MarketsandMarkets is
determined to benefit more than 10,000 companies
this year for their revenue planning and help
them take their innovations/disruptions early to
the market by providing them research ahead of
the curve.   MarketsandMarketss flagship
competitive intelligence and market research
platform, "RT" connects over 200,000 markets and
entire value chains for deeper understanding of
the unmet insights along with market sizing and
forecasts of niche markets.   
http//www.marketsandmarkets.com/Market-Reports/no
rth-american-drug-delivery-technologies-market-120
9.html
7
Contact Us
Mr. Rohan MarketsandMarkets 701 Pike Street
Suite 2175, Seattle, WA 98101, United States
Tel [phone] Email sales_at_marketsandmarket
s.com MarketsandMarkets Bloghttp//www.marketsan
dmarkets.comhttp//twitter.com/marketsmarkets htt
p//www.linkedin.com/company/marketsandmarkets